Incidence Trends for SARS-CoV-2 Alpha and Beta Variants, Finland, Spring 2021.

Alpha variant Beta variant COVID-19 Finland SARS-CoV-2 coronavirus disease epidemiology infectious disease transmission phylogeny public health surveillance respiratory infections severe acute respiratory syndrome coronavirus 2 vaccination vaccines viruses

Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
12 2021
Historique:
pubmed: 29 10 2021
medline: 25 11 2021
entrez: 28 10 2021
Statut: ppublish

Résumé

Severe acute respiratory syndrome coronavirus 2 Alpha and Beta variants became dominant in Finland in spring 2021 but had diminished by summer. We used phylogenetic clustering to identify sources of spreading. We found that outbreaks were mostly seeded by a few introductions, highlighting the importance of surveillance and prevention policies.

Identifiants

pubmed: 34708686
doi: 10.3201/eid2712.211631
pmc: PMC8632157
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3137-3141

Références

Euro Surveill. 2021 Jun;26(24):
pubmed: 34142653
Nature. 2021 Apr;592(7854):438-443
pubmed: 33690265
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Nat Commun. 2021 Jun 28;12(1):3991
pubmed: 34183681
PLoS One. 2019 Aug 22;14(8):e0221068
pubmed: 31437182
Science. 2021 May 21;372(6544):815-821
pubmed: 33853970
Virus Evol. 2021 Jul 30;7(2):veab064
pubmed: 34527285
Nature. 2021 May;593(7858):270-274
pubmed: 33723411
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
Viruses. 2021 May 26;13(6):
pubmed: 34073577

Auteurs

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH